Gene therapy patients with new cancers sought for testing
NCT ID NCT06357754
Summary
This study is a testing service, not a treatment. It aims to analyze tumor samples from patients who received a specific Bristol-Myers Squibb gene therapy for blood cancers and later developed a second, unrelated cancer. The goal is to check if genetic material from the original therapy is present in the new tumor, helping researchers understand potential long-term risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Huntsman Cancer Institute at the University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact
-
Kantonsspital Aarau
RECRUITINGAarau, 5001, Switzerland
Contact Phone: •••-•••-••••
-
Local Institution - 0003
WITHDRAWNKumamoto, Kumamoto, 8608556, Japan
-
Local Institution - 0004
WITHDRAWNMadison, Wisconsin, 53792, United States
-
Local Institution - 0016
NOT_YET_RECRUITINGPortland, Oregon, 97239-3098, United States
Contact
-
Toyokawa City Hospital
RECRUITINGToyokawa, Aichi-ken, 442-8561, Japan
Contact
-
Universitaetsklinikum Essen (AoR)
RECRUITINGEssen, 45147, Germany
Contact Phone: •••-•••-••••
-
Ut Southwestern
RECRUITINGDallas, Texas, 75235, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.